The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, MeVis Medical Solutions AG's share price is €26.40.
MeVis Medical Solutions AG's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €9.53. Hence, MeVis Medical Solutions AG's PS Ratio for today is 2.77.
The historical rank and industry rank for MeVis Medical Solutions AG's PS Ratio or its related term are showing as below:
XTER:M3V'
s PS Ratio Range Over the Past 10 Years
Min: 1.28 Med: 3.27 Max: 4.63
Current: 2.71
During the past 13 years, MeVis Medical Solutions AG's highest PS Ratio was 4.63. The lowest was 1.28. And the median was 3.27.
XTER:M3V's PS Ratio is ranked worse than 64.47% of 653
companies
in the Healthcare Providers & Services industry
Industry Median: 1.57
vs XTER:M3V: 2.71
MeVis Medical Solutions AG revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of MeVis Medical Solutions AG was -7.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 0.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -0.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.70% per year.
During the past 13 years, MeVis Medical Solutions AG's highest 3-Year average Revenue per Share Growth Rate was 11.10% per year. The lowest was -19.20% per year. And the median was -0.55% per year.
Back to Basics: PS Ratio
MeVis Medical Solutions AG PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MeVis Medical Solutions AG's PS Ratio
For the Health Information Services subindustry, MeVis Medical Solutions AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG's PS Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's PS Ratio falls into.
MeVis Medical Solutions AG PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
MeVis Medical Solutions AG's Share Price of today is €26.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MeVis Medical Solutions AG's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €9.53.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
MeVis Medical Solutions AG (XTER:M3V) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
MeVis Medical Solutions AG PS Ratio Related Terms
Thank you for viewing the detailed overview of MeVis Medical Solutions AG's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
MeVis Medical Solutions AG (XTER:M3V) Business Description
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:M3V has been successfully added to your 